Skip to main content
. 2016 Feb 26;60(3):1500–1508. doi: 10.1128/AAC.01763-15

FIG 1.

FIG 1

Flowchart illustrating the numbers of eligible patients, included patients, and episodes, divided into those for patients receiving ≥7 days of exposure to azoles (93), echinocandins (62), polyenes (7), or a combination thereof (26). The total numbers of episodes for patients exposed to azoles, echinocandins, and polyenes for ≥7 days (irrespective of sequential or concomitant additional treatment) were 114, 85, and 16, respectively.